Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.

Blood
Miguel A SanzFrancesco Lo-Coco

Abstract

Since the comprehensive recommendations for the management of acute promyelocytic leukemia (APL) reported in 2009, several studies have provided important insights, particularly regarding the role of arsenic trioxide (ATO) in frontline therapy. Ten years later, a European LeukemiaNet expert panel has reviewed the recent advances in the management of APL in both frontline and relapse settings in order to develop updated evidence- and expert opinion-based recommendations on the management of this disease. Together with providing current indications on genetic diagnosis, modern risk-adapted frontline therapy, and salvage treatment, the review contains specific recommendations for the identification and management of the most important complications such as the bleeding disorder APL differentiation syndrome, QT prolongation, and other all-trans retinoic acid- and ATO-related toxicities, as well as recommendations for molecular assessment of the response to treatment. Finally, the approach to special situations is also discussed, including management of APL in children, elderly patients, and pregnant women. The most important challenges remaining in APL include early death, which still occurs before and during induction therapy, and...Continue Reading

Associated Clinical Trials

Sep 24, 2020·Nidia Paulina Zapata-Canto

References

Aug 12, 2008·Seminars in Oncology·Sylvie D FreemanDavid Grimwade
Jun 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David GrimwadeAlan K Burnett
Oct 14, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Rajasekar ThirugnanamVikram Mathews
Apr 5, 2012·Evaluation & the Health Professions·P Cristian GugiuKristin A Hobson
Jun 21, 2012·Blood·Harry J IlandUNKNOWN Australasian Leukaemia and Lymphoma Group
Dec 12, 2012·Leukemia·A K BurnettUNKNOWN United Kingdom National Cancer Research Institute Acute Myeloid Leukaemia Subgroup
Jul 12, 2013·The New England Journal of Medicine·Francesco Lo-CocoUNKNOWN Study Alliance Leukemia
Oct 16, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hong-Hu ZhuXiao-Jun Huang
Apr 3, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jennifer L Holter ChakrabartyMartin S Tallman
May 9, 2014·The New England Journal of Medicine·Hong-Hu ZhuXiao-Jun Huang
Sep 24, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gail J RobozPaul D Kligfield
Jan 15, 2015·Journal of the National Comprehensive Cancer Network : JNCCN·C Cameron YinCarlos E Bueso-Ramos
Sep 19, 2015·The Lancet Oncology·Alan K BurnettUNKNOWN UK National Cancer Research Institute Acute Myeloid Leukaemia Working Group
Apr 19, 2016·Bone Marrow Transplantation·C GanzelM S Tallman
Jul 13, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Uwe PlatzbeckerFrancesco Lo-Coco

❮ Previous
Next ❯

Citations

Apr 27, 2019·Annals of Hematology·Emanuele Ammatuna, Gerwin Huls
Jan 24, 2020·Blood Advances·Hannah McCalmontRichard J D'Andrea
Feb 6, 2020·Journal of Clinical Medicine·Lara CostantiniNicolò Merendino
Feb 6, 2020·British Journal of Pharmacology·Yishan YeFlorent Malard
Jan 12, 2020·Cancer Metastasis Reviews·Shannon E Conneely, Rachel E Rau
Mar 28, 2020·Oncotarget·Joaquin J JimenezAndrew V Schally
May 20, 2020·British Journal of Haematology·Isabel FarmerTullie Yeghen
Jun 26, 2020·Technology in Cancer Research & Treatment·Natthaporn SasijareonratWeerapat Owattanapanich
Jun 12, 2020·Clinical Transplantation·Hamza Hashmi, Taiga Nishihori
Feb 1, 2020·Current Treatment Options in Oncology·Sebastian SchwindUwe Platzbecker
Apr 2, 2020·Case Reports in Hematology·Claire CochetYohan Desbrosses
Apr 25, 2020·International Journal of Molecular Sciences·Ina NepstadHåkon Reikvam
Jun 12, 2020·International Journal of Hematology·Hideho HenzanUNKNOWN Fukuoka Blood & Marrow Transplantation Group (FBMTG)
Sep 4, 2020·Annals of Hematology·Hitoshi MinamiguchiUNKNOWN Japan Adult Leukemia Study Group
Sep 8, 2019·Cancers·Gledson L PicharskiBonald C Figueiredo
Feb 7, 2020·Cancers·Alberto M MartelliJames A McCubrey
Apr 17, 2020·Cancers·Marie-Claude Geoffroy, Hugues de Thé
Jun 6, 2019·Frontiers in Oncology·Danielle GolubDimitris G Placantonakis
Nov 7, 2019·British Journal of Haematology·Firas El Chaer, Karen K Ballen
Aug 13, 2020·International Journal of Molecular Sciences·Laurène FenwarthNicolas Duployez
Aug 1, 2020·Pharmaceutics·Maria Valeria GiuliMaria Carafa
Mar 21, 2020·Cancers·Elise AasebøMaria Hernandez-Valladares
Feb 12, 2020·International Journal of Molecular Sciences·Fabio ForghieriMario Luppi
Sep 27, 2019·Frontiers in Oncology·Judith SchütteChristine Eisfeld
Nov 1, 2020·Blood Cancer Journal·Naval DaverCourtney D DiNardo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.